Tumor Ablation Market to Reach US$1.9 Billion by 2024: Rising Prevalence of Cancer to Produce Lucrative Opportunity for Growth

Wednesday, March 22, 2017 Research News
Email Print This Page Comment bookmark
Font : A-A+

ALBANY, New York, March 22, 2017 /PRNewswire/ --

According to a research report by Transparency Market Research (TMR),

the global tumor ablation market is fragmented and highly competitive in nature, owing to the presence of a large number of market participants. As the market hold enormous potential for growth, pharmaceutical companies continue to enter in this market,
intensifying the competition within.

The leading players are expected to focus on product innovation and technological advancements in current offerings to strengthen their position in this market over the coming years. Jude Medical, BVM Medical, Boston Scientific, BTG International, and Medtronic are some of the key players in this market, mentions the research study.

TMR estimates the global market for tumor ablation to rise from US$7.02 bn in 2015 to a value of US$1.9 bn by 2024, progressing at a CAGR of 12.20% during the period from 2016 to 2024. The radiofrequency ablation technology segment, which has been dominating the global market over the last few years, is likely to retain its position throughout the forecast period

Browse Market Research Report @ http://www.transparencymarketresearch.com/tumor-ablation-market.html

Advancements in Tumor Ablation Technology to Ensure Dominance of North America 

The report also analyzes the worldwide market for tumor ablation on the basis of geography. As per the study, Asia Pacific, the Middle East and Africa, North America, Latin America, and Europe are the key segments of this market, geographically. North America occupied the top position in this market in 2015 with a share of 30%, thanks to the early adoption of the tumor ablation technology. Researchers predict this regional market to continue its growth streak throughout the forecast period, supported by the technological advancements in ablation technologies, rising prevalence of cancer, and the increasing base of geriatric population.

Europe and Asia Pacific are also anticipated to witness prominent growth in their market shares over the next few years, states the research report. The Europe market for tumor ablation is expected to be propelled further by the rising consumption of tobacco and alcohol, a large geriatric population base, increase in research activities, and the surging awareness level among people in this region. Asia Pacific, on the other hand, is projected to be driven by the presence of high unmet medical needs, escalating medical expenditures in emerging economies, increasing investment in research and development activities in the medical and healthcare sector, and the growing attention of key market participants on this region.

Fill the form for an exclusive sample of this report @ http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=18656

Rising Popularity of Tumor Ablation Technology to Reflect Positively on its Demand 

"With the significant rise in the incidence rate of cancer in humans, the market for tumor ablation has been gained substantial momentum across the world," states a researcher at TMR. According to the World Health Organization (WHO), nearly 8.8 million people died due to cancer in 2015, globally, establishing it as the second leading cause of death across the world. Since tumor ablations is a highly efficient treatment for cancer with minimal risk of side-effects, its popularity has increased manifolds among medical professional as well as patients, which, as a result, has been reflecting positively on its uptake. The continual advancements in ablation technology are also adding considerably to the growth of this market.

In addition, the rising inclination of patients toward minimally invasive procedures and the growing acceptance of innovative technologies will propel this market remarkably over the forthcoming years. However, the lack of a favorable reimbursement scenario and the high cost associated with research and development may hamper the market's progress in the years to come, notes the study.

The study presented here is based on a report by Transparency Market Research (TMR), titled "Tumor Ablation Market (Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, High-Intensity Focused Ultrasound, and Laser Interstitial Thermal Ablation; Disease Indication - Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, and Prostate Cancer; End Users - Hospitals and Cancer Specialty Clinics) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2014 - 2024."

Browse Press Release: http://www.transparencymarketresearch.com/pressrelease/tumor-ablation-market.htm

The global tumor ablation market has been segmented as follows:

By Technology 

  • Radiofrequency Ablation
  • Microwave Ablation
  • Cryoablation
  • High-Intensity Focused Ultrasound
  • Laser Interstitial Thermal Ablation
  • Others

By Material 

  • Liver cancer
  • Lung cancer
  • Kidney cancer
  • Bone cancer
  • Breast cancer
  • Prostate cancer
  • Others

By End Users 

  • Hospitals
  • Cancer Specialty Clinics
  • Others

By Geography 

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC countries
    • South Africa
    • Rest of MEA

Browse Related Research Report: 

Radiofrequency Ablation Devices for Pain Management Market (Product - RF Generators, Reusable Products, and Disposable Products; End-user - Specialty Clinics, Ambulatory Surgical Centers, and Hospitals) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024


Kidney Cancer Drugs Market (Major Drugs: Afinitor (Everolimus), Avastin (Bevacizumab), Inlyta (Axitinib), Nexavar (Sorafenib), Proleukin (Aldesleukin), Sutent (Sunitinib), Torisel (Temsirolimus), Votrient (Pazopanib)) - Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020


Breast Cancer Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023


About Us: 

Transparency Market Research (TMR) is a U.S. based provider of syndicated research, customized research, and consulting services. TMR's global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact Us: Transparency Market Research 90 State Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

Blog: http://www.tmrblog.com/

SOURCE Transparency Market Research


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store